Imescia, a spin-off company from the Institut Galien Paris-Saclay @umr8612, aims to deliver the best anticancer treatments to patients by a simple SC injection
Please wait while we extract and analyse the requested data.
This can take a few minutes due to the large amount of data to be searched through, extracted and analysed. Please don't reload the page in the mean time as this will only result in it taking longer.
For access to this functionality a Trendsmap Explore subscription is required.
A Trendsmap Explore subscription provides full access to all available timeframes